Skip to main content
Livermore
Livermore
ZHEN

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
27,419
Value
$4.62M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NBIX by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202627,419$4.62M<0.1%−260−0.9%ReducedHolders
Q1 202627,679$3.65M<0.1%+2,669+10.7%AddedHolders
Q4 202525,010$3.55M<0.1%−1,378−5.2%ReducedHolders
Q3 202526,388$3.70M<0.1%+413+1.6%AddedHolders
Q2 202525,975$3.26M<0.1%−1,307−4.8%ReducedHolders
Q1 202527,282$3.02M<0.1%+215+0.8%AddedHolders
Q4 202427,067$3.69M<0.1%+1,941+7.7%AddedHolders
Q3 202425,126$2.90M<0.1%−102−0.4%ReducedHolders
Q2 202425,228$3.47M<0.1%−436−1.7%ReducedHolders
Q1 202425,664$3.54M<0.1%+4,216+19.7%AddedHolders
Q4 202321,448$2.83M<0.1%−936−4.2%ReducedHolders
Q3 202322,384$2.52M<0.1%−55−0.2%ReducedHolders
Q2 202322,439$2.12M<0.1%−279−1.2%ReducedHolders
Q1 202322,718$2.30M<0.1%+386+1.7%AddedHolders
Q4 202222,332$2.67M<0.1%+1,410+6.7%AddedHolders
Q3 202220,922$2.22M<0.1%+57+0.3%AddedHolders
Q2 202220,865$2.03M<0.1%+537+2.6%AddedHolders
Q1 202220,328$1.91M<0.1%−92−0.5%ReducedHolders
Q4 202120,420$1.74M<0.1%−36−0.2%ReducedHolders
Q3 202120,456$1.96M<0.1%−159−0.8%ReducedHolders
Q2 202120,615$2.01M<0.1%+1,146+5.9%AddedHolders
Q1 202119,469$1.89M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.